| scholarly article | Q13442814 |
| P50 | author | Shimon Sakaguchi | Q17502433 |
| Sergio A Quezada | Q60622517 | ||
| P2093 | author name string | Randolph J Noelle | |
| Li-Fan Lu | |||
| David C Gondek | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1783-1786 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism | |
| P478 | volume | 174 |
| Q56889692 | A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity |
| Q28590646 | A function for interleukin 2 in Foxp3-expressing regulatory T cells |
| Q30826185 | A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation |
| Q33384634 | APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development |
| Q35848308 | Activated CD4+CD25+ T cells selectively kill B lymphocytes |
| Q84945701 | Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer |
| Q36288969 | Allograft rejection mediated by memory T cells is resistant to regulation |
| Q48480477 | Anti-GITR therapy promotes immunity against malignant glioma in a murine model. |
| Q37270469 | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression |
| Q34979858 | Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell |
| Q43418649 | B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion |
| Q53217292 | CCR4 dependent migration of Foxp3+ Treg cells to skin grafts and draining lymph nodes is implicated in enhanced graft survival in CD200tg recipients |
| Q35228053 | CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation |
| Q37317928 | CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus |
| Q33714522 | CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism |
| Q37082777 | CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases. |
| Q37794623 | CD4+ regulatory T cells in solid organ transplantation |
| Q36600237 | CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance |
| Q37754524 | CD4+CD25+ regulatory T-cell therapy |
| Q44491431 | CD4+CD25+CD127dimFoxp3+ T cells are cytotoxic for human neurons |
| Q34709777 | CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells |
| Q34423206 | CD4+CD25+Foxp3+IFNγ+CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells |
| Q36291143 | CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions |
| Q33796410 | CD46-induced human Treg enhance B-cell responses |
| Q45176452 | CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. |
| Q35108103 | CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen |
| Q37520543 | CD8⁺ Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria |
| Q38170150 | Cellular and molecular mechanisms in cancer immune escape: a comprehensive review |
| Q36490768 | Checkpoint blockade in cancer immunotherapy |
| Q64974096 | Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. |
| Q28069832 | Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives |
| Q54397365 | Clinical Significance of Regulatory T-Cell–Related Gene Expression in Peripheral Blood After Renal Transplantation |
| Q84794919 | Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma |
| Q28271806 | Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily |
| Q42934008 | Comment on "Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways". |
| Q55315496 | Common Features of Regulatory T Cell Specialization During Th1 Responses. |
| Q46733558 | Comparison of apoptosis and mortality measurements in peripheral blood mononuclear cells (PBMCs) using multiple methods |
| Q30438088 | Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node |
| Q40115071 | Control of Regulatory T Cell Differentiation by the Transcription Factors Thpok and LRF. |
| Q34133590 | Control of homeostatic proliferation by regulatory T cells |
| Q34054667 | Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B |
| Q37349582 | Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress |
| Q38292676 | Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells. |
| Q33880763 | Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity. |
| Q37597931 | Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? |
| Q37530535 | DNA and protein co-administration induces tolerogenic dendritic cells through DC-SIGN mediated negative signals |
| Q39660421 | DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4. |
| Q34588821 | Death by a thousand cuts: granzyme pathways of programmed cell death |
| Q38124437 | Deciphering and reversing tumor immune suppression. |
| Q35067630 | Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells |
| Q37383315 | Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame |
| Q37045247 | Dendritic cells and T cells in the regulation of cutaneous immunity |
| Q37203108 | Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft |
| Q37547414 | Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection |
| Q36844861 | Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis tre |
| Q26774590 | Disrupted regulatory T cell homeostasis in inflammatory bowel diseases |
| Q33772507 | Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity. |
| Q39928054 | Disturbances in some gene expression in T regulatory cells separated from children with metabolic syndrome. |
| Q35642843 | Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease |
| Q64982406 | Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. |
| Q45403301 | Effects of CD4(+)CD25(+)Foxp3(+)regulatory T cells on early Plasmodium yoelii 17XL infection in BALB/c mice |
| Q36486882 | Emerging possibilities in the development and function of regulatory T cells |
| Q38107700 | Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity |
| Q56897895 | Epicutaneous immunization with DNP-BSA induces CD4+ CD25+ Treg cells that inhibit Tc1-mediated CS |
| Q51629955 | Estradiol-dependent perforin expression by human regulatory T-cells. |
| Q35530818 | Evaluation of immunosuppressive function of regulatory T cells using a novel in vitro cytotoxicity assay |
| Q56886145 | Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells: A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade |
| Q37294572 | Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy |
| Q37610691 | Excessive expression of miR-27 impairs Treg-mediated immunological tolerance. |
| Q26779184 | Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy |
| Q29307487 | FOXP3+ regulatory T cells in the human immune system |
| Q37937127 | FOXP3+ regulatory T cells: From suppression of rejection to induction of renal allograft tolerance |
| Q37828869 | FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents |
| Q37804609 | FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells |
| Q33706998 | Foxp3 expression in p53-dependent DNA damage responses |
| Q36786930 | Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation |
| Q45922599 | Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. |
| Q35552966 | Foxp3+-Inducible Regulatory T Cells Suppress Endothelial Activation and Leukocyte Recruitment |
| Q33987128 | Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q36984057 | Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation |
| Q90588415 | Future prospects for CD8+ regulatory T cells in immune tolerance |
| Q34615533 | GITR/GITRL: more than an effector T cell co-stimulatory system. |
| Q36938160 | Generation and function of induced regulatory T cells |
| Q51004166 | Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice |
| Q34008970 | Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| Q26765438 | Genetics and biology of pancreatic ductal adenocarcinoma |
| Q35551328 | Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells. |
| Q36546727 | Good syndrome presenting with CD8⁺ T-Cell large granular lymphocyte leukemia |
| Q35619237 | Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease |
| Q35613097 | Granzyme B Regulates Antiviral CD8+ T Cell Responses |
| Q34308243 | Granzyme B in injury, inflammation, and repair |
| Q33706382 | Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. |
| Q30496008 | Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. |
| Q35912982 | Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cells |
| Q34955529 | Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection |
| Q35010452 | Granzymes and perforin in solid organ transplant rejection |
| Q34097453 | Granzymes in age-related cardiovascular and pulmonary diseases |
| Q30435033 | HCV+ Hepatocytes Induce Human Regulatory CD4+ T Cells through the Production of TGF-β |
| Q42207253 | HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. |
| Q34540245 | HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells |
| Q35624877 | Harnessing regulatory T cells for the treatment of inflammatory bowel disease. |
| Q37680540 | Harnessing regulatory T cells to suppress asthma: from potential to therapy |
| Q92018196 | High expression of granzyme B in conventional CD4+ T cells is associated with increased relapses after allogeneic stem cells transplantation in patients with hematological malignancies |
| Q43514433 | High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment |
| Q26853599 | Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs |
| Q54568607 | How many mechanisms do regulatory T cells need? |
| Q29614262 | How regulatory T cells work |
| Q84639319 | Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help |
| Q61711484 | Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells |
| Q52717949 | Human Cancer and Platelet Interaction, a Potential Therapeutic Target. |
| Q37040516 | Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis |
| Q42108248 | Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis |
| Q36488883 | Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. |
| Q37598166 | Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody |
| Q47275057 | Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation |
| Q36227516 | IFNy+ and IFNy- Treg subsets with stable and unstable Foxp3 expression in kidney transplant recipients with good long-term graft function |
| Q36395621 | IFNγR signaling mediates alloreactive T-cell trafficking and GVHD |
| Q36509935 | IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy |
| Q43125547 | IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells |
| Q41825508 | IL-2-deprivation and TGF-beta are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25- cell activation. |
| Q82292256 | Identification of a unique double-negative regulatory T-cell population |
| Q36691045 | Identification of early myeloid progenitors as immunosuppressive cells |
| Q94470282 | Immune Suppression in Pregnancy and Cancer: Parallels and Insights |
| Q38154343 | Immune mechanisms in hypertension and vascular injury |
| Q37864694 | Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells |
| Q37823689 | Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells |
| Q80236699 | Immunopathogenesis of psoriasis |
| Q84257326 | Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response |
| Q33709232 | Immunotherapy for solid tumors--a review for surgeons |
| Q92412497 | Impaired tumor necrosis factor-α secretion by CD4 T cells during respiratory syncytial virus bronchiolitis associated with recurrent wheeze |
| Q33855759 | Impairment of Granzyme B-Producing Regulatory B Cells Correlates with Exacerbated Rheumatoid Arthritis |
| Q96131145 | In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice |
| Q33997187 | In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. |
| Q38574966 | In vivo induction of regulatory T cells for immune tolerance in hemophilia |
| Q42076470 | In vivo sites and cellular mechanisms of T reg cell-mediated suppression |
| Q33770196 | Induced Regulatory T Cells Superimpose Their Suppressive Capacity with Effector T Cells in Lymph Nodes via Antigen-Specific S1p1-Dependent Egress Blockage |
| Q36948341 | Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease |
| Q39785440 | Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation |
| Q47252494 | Induction of Immunosuppressive CD8+CD25+FOXP3+ Regulatory T Cells by Suboptimal Stimulation with Staphylococcal Enterotoxin C1. |
| Q30907499 | Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway |
| Q83120989 | Inflammation in vivo is modulated by GPR83 isoform-4 but not GPR83 isoform-1 expression in regulatory T cells |
| Q37000445 | Inhibition of lung metastasis by chemokine CCL17-mediated in vivo silencing of genes in CCR4+ Tregs |
| Q84819752 | Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation |
| Q54983048 | Innate immunity and effector and regulatory mechanisms involved in allergic contact dermatitis. |
| Q37350929 | Interferon-Gamma Receptor Signaling Plays an Important Role in Restraining Murine Ovarian Tumor Progression |
| Q37440379 | Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance |
| Q44996678 | Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells |
| Q34655265 | Interleukin-2-dependent mechanisms of tolerance and immunity in vivo |
| Q37492932 | Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4+CD25+ Regulatory T Cells |
| Q46369670 | Interleukin-4 suppresses the cytotoxic potential of in vitro generated, adaptive regulatory CD4 T cells by down-regulation of granzyme B. |
| Q34089124 | Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection |
| Q80972826 | Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells |
| Q82551194 | Is liver‐targeted FOXp3 staining beneficial after living‐donor liver transplantation? |
| Q91973468 | JunB Controls Intestinal Effector Programs in Regulatory T Cells |
| Q41926775 | Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. |
| Q36227859 | LAT-mediated signaling in CD4+CD25+ regulatory T cell development |
| Q83921292 | Lack of IL-2 in PPAR-α-deficient mice triggers allergic contact dermatitis by affecting regulatory T cells |
| Q45952178 | Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. |
| Q87213112 | Loss of Immunization-Induced Epitope-Specific CD4 T-Cell Response following Anaplasma marginale Infection Requires Presence of the T-Cell Epitope on the Pathogen and Is Not Associated with an Increase in Lymphocytes Expressing Known Regulatory Cell |
| Q54317518 | MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu |
| Q51997055 | Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. |
| Q34559099 | Mast cells are essential intermediaries in regulatory T-cell tolerance |
| Q37317297 | Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models |
| Q36988144 | Mechanisms of granule-dependent killing |
| Q85945994 | Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation |
| Q34847859 | Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells. |
| Q93247005 | Microbiome modulates intestinal homeostasis against inflammatory diseases |
| Q28393614 | Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics |
| Q50671091 | Molecular Mechanisms of Regulatory T Cell Development and Suppressive Function |
| Q38008361 | Molecular Mechanisms of Treg-Mediated T Cell Suppression |
| Q26765845 | NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment |
| Q37968236 | NKT cell self-reactivity: evolutionary master key of immune homeostasis? |
| Q53523527 | Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression |
| Q34676250 | Natural regulatory T cells in autoimmunity |
| Q33869793 | Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression |
| Q27001081 | Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses |
| Q53471307 | New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells |
| Q34331993 | New roads open up for implementing immunotherapy in mesothelioma |
| Q35595880 | Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. |
| Q56888845 | Novel Effector Phenotype of Tim-3 Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients |
| Q38614686 | Novel therapeutic and diagnostic management of heart transplant patients |
| Q37180457 | OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential. |
| Q38013107 | On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation |
| Q28081922 | Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells |
| Q37312476 | Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo |
| Q34733541 | Parasitic nematode-induced CD4+Foxp3+T cells can ameliorate allergic airway inflammation |
| Q34248293 | Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo |
| Q36425407 | Peripheral Regulatory Cells Immunophenotyping in Kidney Transplant Recipients with Different Clinical Profiles: A Cross-Sectional Study |
| Q37620098 | Plasmacytoid dendritic cells: physiologic roles and pathologic states. |
| Q37287156 | Positive and negative influences of regulatory T cells on tumour immunity. |
| Q38235166 | Potential and limitations of regulatory T-cell therapy in solid organ transplantation. |
| Q92400296 | Preferential Homing of Tumor-specific and Functional CD8+ Stem Cell-like Memory T Cells to the Bone Marrow |
| Q33968779 | Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge. |
| Q37754132 | Prognostic significance of regulatory T cells in tumor |
| Q34215381 | Progress in understanding the immunopathogenesis of psoriasis |
| Q38097917 | Promoting transplantation tolerance; adoptive regulatory T cell therapy |
| Q84347834 | Pulling the Trigger on the Tumor‘s Bodyguards: What Puts Tregs Out of Action? |
| Q43708939 | RSV infection--an immune balancing act: commentary on the article by Bem et al. on page 650. |
| Q37002025 | Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation |
| Q37184443 | Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2). |
| Q33648194 | Redox remodeling as an immunoregulatory strategy |
| Q26823216 | Regulation generation: the suppressive functions of human regulatory T cells |
| Q37128687 | Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids |
| Q37835495 | Regulation of T cell activation by TLR ligands |
| Q36148406 | Regulation of immunity by self-reactive T cells |
| Q38497066 | Regulatory B cells in anti-tumor immunity |
| Q64949232 | Regulatory Role of CD4+ T Cells in Myocarditis. |
| Q36462109 | Regulatory T Cell Immunotherapy in Immune-Mediated Diseases |
| Q38057738 | Regulatory T Cell Induction, Migration, and Function in Transplantation |
| Q38948512 | Regulatory T Cells and Cancer: A Two-Sided Story |
| Q33715605 | Regulatory T Cells in Allergy and Asthma. |
| Q26746113 | Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation |
| Q26784460 | Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation |
| Q37725749 | Regulatory T cell as a target for cancer therapy |
| Q44440268 | Regulatory T cell development in the absence of functional Foxp3. |
| Q39823591 | Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival |
| Q26991447 | Regulatory T cell: a protection for tumour cells |
| Q37776686 | Regulatory T cells (Treg) and Their Roles in Immune System with Respect to Immunopathological Disorders |
| Q42577777 | Regulatory T cells and Atherosclerosis |
| Q58775100 | Regulatory T cells and asthma |
| Q37599669 | Regulatory T cells and immune tolerance to tumors |
| Q37272005 | Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation |
| Q37695072 | Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS. |
| Q34125717 | Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner |
| Q35765491 | Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. |
| Q30409790 | Regulatory T cells in AKI. |
| Q45066685 | Regulatory T cells in Acute and Chronic Kidney Diseases |
| Q35553553 | Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation? |
| Q38946820 | Regulatory T cells in allergic diseases. |
| Q84073243 | Regulatory T cells in cancer |
| Q38622693 | Regulatory T cells in cardiovascular diseases |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q36863866 | Regulatory T cells in health and disease |
| Q36949181 | Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border |
| Q57471979 | Regulatory T cells in the treatment of disease |
| Q37691776 | Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? |
| Q39957163 | Regulatory T cells in transplantation: what we know and what we do not know |
| Q47154701 | Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells |
| Q90518726 | Regulatory T cells promote corneal endothelial cell survival following transplantation via interleukin-10 |
| Q36430144 | Regulatory T cells, tumour immunity and immunotherapy |
| Q26827787 | Regulatory T cells: Mechanisms of suppression and impairment in autoimmune liver disease |
| Q37593768 | Regulatory T cells: how do they suppress immune responses? |
| Q29620731 | Regulatory T cells: mechanisms of differentiation and function |
| Q36484595 | Regulatory T cells: present facts and future hopes. |
| Q37697589 | Regulatory T cells: roles of T cell receptor for their development and function |
| Q37049217 | Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? |
| Q37309438 | Regulatory T-Cell Therapy for Graft-versus-host Disease |
| Q37834024 | Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis |
| Q36891917 | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. |
| Q54329903 | Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression |
| Q33664082 | Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells |
| Q36539633 | Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis |
| Q26798141 | Research Progress on Regulatory T Cells in Acute Kidney Injury |
| Q99585601 | Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion |
| Q93347701 | Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells |
| Q37854959 | Retinoic Acid, Immunity, and Inflammation |
| Q90288573 | Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation |
| Q41515965 | Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity |
| Q37729059 | Role of T cells in graft rejection and transplantation tolerance. |
| Q21132345 | Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation |
| Q37107677 | Role of regulatory T cells during virus infection |
| Q37090518 | Role of regulatory T cells in gastrointestinal inflammatory disease |
| Q28742855 | SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism |
| Q40360057 | STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cells |
| Q37097934 | Selective elimination of autoreactive T cells in vivo by the regulatory T cells |
| Q30574368 | Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. |
| Q37701348 | Self-tolerance and autoimmunity in a regulatory T cell model |
| Q37126477 | Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. |
| Q37112525 | Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells |
| Q38732326 | Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice |
| Q64084505 | Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner |
| Q89621603 | Stromal Vascular Fraction and its Role in the Management of Alopecia: A Review |
| Q36512526 | Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancers |
| Q52681524 | Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells |
| Q38006901 | T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis |
| Q36684909 | T-cell regulation: with complements from innate immunity |
| Q37902883 | T-helper cells in the etiopathogenesis of periodontal disease: A mini review |
| Q89209907 | TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice |
| Q36685552 | TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma |
| Q90320536 | Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells |
| Q37983467 | Targeting regulatory T cells |
| Q28078919 | The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation |
| Q37088900 | The Foxp3+ regulatory T cell: a jack of all trades, master of regulation |
| Q97521477 | The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover |
| Q24633549 | The PD-1 pathway in tolerance and autoimmunity |
| Q37393703 | The T(reg)/Th17 cell balance: a new paradigm for autoimmunity |
| Q87628572 | The ThPOK transcription factor differentially affects the development and function of self-specific CD8(+) T cells and regulatory CD4(+) T cells |
| Q33769528 | The Type of Responder T-Cell Has a Significant Impact in a Human In Vitro Suppression Assay |
| Q39441289 | The Untold Story of Granzymes in Oncoimmunology: Novel Opportunities with Old Acquaintances. |
| Q37633282 | The battlefield of perforin/granzyme cell death pathways. |
| Q45370941 | The control of CD8+ T cell responses is preserved in perforin-deficient mice and released by depletion of CD4+CD25+ regulatory T cells |
| Q37728840 | The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease |
| Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
| Q37274250 | The development and function of regulatory T cells |
| Q41462842 | The duration of T cell stimulation is a critical determinant of cell fate and plasticity. |
| Q37112199 | The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells |
| Q37542878 | The enigmatic role of mast cells in dominant tolerance |
| Q36481704 | The hidden truth about gene expression in Tregs: is it what you don't see that counts? |
| Q28257250 | The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells |
| Q54518671 | The paradox role of regulatory T cells in ischemic stroke |
| Q37564741 | The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease |
| Q34009654 | The power and the promise of restimulation-induced cell death in human immune diseases |
| Q42208547 | The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts |
| Q36814760 | The role of Granzyme B in atheromatous diseases |
| Q36752196 | The role of natural regulatory T cells in infection |
| Q30441254 | The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function |
| Q39295050 | The role of regulatory T cells in nervous system pathologies |
| Q38035240 | The role of regulatory T cells in neurodegenerative diseases |
| Q36946019 | The tumor microenvironment and its role in promoting tumor growth |
| Q36107084 | Thymic stromal lymphopoietin is a key mediator of breast cancer progression |
| Q36959215 | Thymic versus induced regulatory T cells - who regulates the regulators? |
| Q42071282 | Tim-3 Pathway Controls Regulatory and Effector T Cell Balance during Hepatitis C Virus Infection |
| Q36104784 | Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q36841068 | Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4(+) T cell responses through TLR4 ligation. |
| Q84173847 | Transfer of cell membrane components via trogocytosis occurs in CD4+Foxp3+CD25+regulatory T-cell contact-dependent suppression |
| Q42091259 | Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells |
| Q37321716 | Treatment of graft-versus-host disease with naturally occurring T regulatory cells |
| Q91768573 | Treg cell-based therapies: challenges and perspectives |
| Q38779612 | Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets |
| Q57811623 | Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy |
| Q34608828 | Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation |
| Q37213940 | Tuberculosis vaccine development: goals, immunological design, and evaluation |
| Q37788679 | Tumor Infiltrating Regulatory T Cells: Tractable Targets for Immunotherapy |
| Q38058493 | Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms |
| Q63437314 | Tumor microenvironment participates in metastasis of pancreatic cancer |
| Q36602010 | Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells. |
| Q64108546 | Turning the Tide Against Regulatory T Cells |
| Q26823898 | Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients |
| Q47986758 | Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down? |
| Q34612865 | Virus expanded regulatory T cells control disease severity in the Theiler’s virus mouse model of MS |
| Q41897453 | WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells |
| Q41894399 | Why do human B cells secrete granzyme B? Insights into a novel B-cell differentiation pathway |
| Q36194834 | Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001 |
Search more.